Needham Reiterates Buy Rating on Cormedix, Keeps $15 Target
Needham reiterated its Buy rating on Cormedix and maintained a $15 price target. The target implies 106.6% upside from the October 16 close of $7.26.
Story updates
05:25:37 PM UTC
SquawkNews
CorMedix Price Target Maintained With a $15.00/Share by Needham